Results of Low-Dose Carperitide Infusion in High-Risk Patients Undergoing Coronary Artery Bypass Grafting
This study investigated the efficacy of human atrial natriuretic peptide (hANP, carperitide) for high-risk patients undergoing coronary artery bypass grafting (CABG).
